(1)
Kwon, D. H. .; Kim, G.-Y. .; Cha, H.-J. .; Kim, S.; Kim, H.-S. .; Hwang, H.-J. .; Choi, Y. H. Nargenicin A1 Attenuates Lipopolysaccharide-Induced Inflammatory and Oxidative Response by Blocking the NF-κB Signaling Pathway. EXCLI J. 2021, 20, 968-982.